高速液体クロマトグラフィー（HPLC）の世界市場予測（～2021年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH METHODOLOGY 19
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.2.1 SECONDARY RESEARCH 20
2.2.1.1 Key data from secondary sources 20
2.2.2 PRIMARY RESEARCH 22
2.2.2.1 Key data from primary sources 23
2.2.2.2 Key insights from primary sources 23
2.2.2.3 Key industry insights 24
2.3 MARKET SIZE ESTIMATION METHODOLOGY 25
2.4 MARKET FORECAST METHODOLOGY 27
2.5 MARKET DATA VALIDATION AND TRIANGULATION 28
2.6 ASSUMPTIONS FOR THE STUDY 29

3 EXECUTIVE SUMMARY 30
3.1 INTRODUCTION 30
3.2 CONCLUSION 35

4 PREMIUM INSIGHTS 36
4.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC): MARKET OVERVIEW 36
4.2 GEOGRAPHIC ANALYSIS: HPLC MARKET, BY APPLICATION (2016) 37
4.3 GLOBAL HPLC MARKET SHARE, BY PRODUCT, 2016 VS. 2021 38
4.4 GEOGRAPHICAL SNAPSHOT OF THE HPLC MARKET 38
 

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 High sensitivity and accuracy of HPLC 41
5.2.1.2 Growing popularity of the LC-MS technique 41
5.2.1.3 Growing importance of HPLC tests in drug approvals 41
5.2.1.4 Increasing life science R&D spending 42
5.2.2 RESTRAINT 42
5.2.2.1 High cost of equipment 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Increasing use of chromatography in the purification of monoclonal antibodies 43
5.2.3.2 Emerging markets in India and China 43
5.2.3.3 Emergence of biobanking 44
5.2.4 CHALLENGE 44
5.2.4.1 Extensive requirements for developing systems that generate pressures above 20,000 psi 44

6 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY PRODUCT 45
6.1 INTRODUCTION 46
6.2 INSTRUMENTS 47
6.2.1 SYSTEMS 48
6.2.2 DETECTORS 49
6.2.3 PUMPS 50
6.2.4 FRACTION COLLECTORS 51
6.3 CONSUMABLES 52
6.3.1 COLUMNS 53
6.3.1.1 Reverse-phase HPLC columns 54
6.3.1.2 Normal-phase/hydrophilic interaction HPLC columns 55
6.3.1.3 Ion exchange HPLC columns 56
6.3.1.4 Other columns 57
6.3.2 FILTERS 59
6.3.3 VIALS 60
6.3.4 TUBES 61
6.4 ACCESSORIES 62
 

7 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY APPLICATION 63
7.1 INTRODUCTION 64
7.2 CLINICAL RESEARCH 65
7.3 DIAGNOSTICS 67
7.4 FORENSICS 68
7.5 OTHER APPLICATIONS 70

8 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION 71
8.1 INTRODUCTION 72
8.2 NORTH AMERICA 74
8.2.1 U.S. 78
8.2.1.1 Increasing funding for R&D 78
8.2.1.2 Preclinical activities by CROs and pharmaceutical companies 78
8.2.1.3 U.S.-China collaborative program for biomedical research 78
8.2.2 CANADA 81
8.2.2.1 Government initiatives to improve laboratory infrastructure 81
8.2.2.2 Growth in the food testing industry in Ontario 82
8.2.2.3 Growing intensity of pharmaceutical and biopharmaceutical clinical research 82
8.3 EUROPE 86
8.3.1 GERMANY 90
8.3.1.1 Flourishing biotechnology and life sciences industry 90
8.3.2 U.K. 93
8.3.2.1 Increased investments in pharmaceutical development 93
8.3.3 REST OF EUROPE (ROE) 96
8.3.3.1 Focus of the pharmaceutical market players to enhance their presence in France 96
8.3.3.2 Funding from local and government agencies in Spain 96
8.3.3.3 Russia’s booming pharmaceutical industry 97
8.4 ASIA-PACIFIC (APAC) 100
8.4.1 JAPAN 104
8.4.1.1 Growth in biomedical and medical research in Japan 104
8.4.2 CHINA 107
8.4.2.1 Strategic expansions by key players in China 107
8.4.2.2 Outsourcing of clinical research activities to China 107
8.4.3 INDIA 110
8.4.3.1 Increasing government initiatives and growing pharmaceutical industry in India 110
8.4.4 REST OF ASIA-PACIFIC (ROAPAC) 113
8.4.4.1 Favorable regulatory scenario in New Zealand and Australia 113
 
8.5 REST OF THE WORLD (ROW) 116
8.5.1 LATIN AMERICA 120
8.5.1.1 Growth in the biotechnology & pharmaceutical industries in Brazil 120
8.5.2 MIDDLE EAST AND AFRICA (MEA) 123
8.5.2.1 Favorable business environment for pharmaceutical and biotechnology industries in Saudi Arabia and the UAE 123
8.5.2.2 Increasing focus of pharmaceutical companies in Africa 123

9 COMPETITIVE LANDSCAPE 127
9.1 OVERVIEW 127
9.2 MARKET SHARE ANALYSIS 127
9.2.1 INTRODUCTION 127
9.2.2 WATERS CORPORATION 128
9.2.3 AGILENT TECHNOLOGIES, INC. 128
9.2.4 SHIMADZU CORPORATION 129
9.3 EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES 130
9.4 COMPETITIVE SITUATION AND TRENDS 131
9.4.1 PRODUCT LAUNCHES 131
9.4.2 EXPANSIONS 133
9.4.3 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 134
9.4.4 ACQUISITIONS 135
9.4.5 OTHER STRATEGIES 136

10 COMPANY PROFILES 138
(Overview, Products and Services, Financials, Strategy & Development)*
10.1 INTRODUCTION 138
10.2 WATERS CORPORATION 139
10.3 AGILENT TECHNOLOGIES, INC. 143
10.4 SHIMADZU CORPORATION 148
10.5 THERMO FISHER SCIENTIFIC INC. 152
10.6 GE HEALTHCARE 156
10.7 PERKINELMER, INC. 159
10.8 BIO-RAD LABORATORIES, INC. 162
10.9 GILSON, INC. 164
10.10 PHENOMENEX, INC. 165
10.11 JASCO, INC. 167
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
 

11 APPENDIX 169
11.1 DISCUSSION GUIDE 169
11.2 OTHER DEVELOPMENTS 172
11.2.1 WATERS CORPORATION 172
11.2.2 AGILENT TECHNOLOGIES, INC. 173
11.2.3 SHIMADZU CORPORATION 174
11.2.4 THERMO FISHER SCIENTIFIC INC. 175
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 177
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 179
11.5 AVAILABLE CUSTOMIZATIONS 180
11.6 RELATED REPORTS 181
11.7 AUTHOR DETAILS 182